Fig. 1From: Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumoniaLactate dehydrogenase (LDH) levels were determined in COVID-19 pneumonia patients during hospitalization. a differences in LDH levels were found between non-severe group and severe group (P < 0.05). b, c the values of LDH selected from the data of admission, peak progress on CT (PPC) and remarkable absorption on CT (RAC) were compared (P < 0.05). Notable, in some cases, the data of admission was under the peak course of diseaseBack to article page